| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |